Why the study?
Does the Hemopump temporary cardiac assist system provide effective left ventricular assistance in a patient with peripartum cardiomyopathy?
Does the Hemopump temporary cardiac assist system provide effective left ventricular assistance in a patient with peripartum cardiomyopathy?
The Hemopump temporary cardiac assist system can provide life-saving left ventricular support in patients with peripartum cardiomyopathy.
Answers are grounded in this paper and cite their sources.
May support Hemopump for LV assistance in peripartum cardiomyopathy; leaves open need for prospective trials before wider use.
The Hemopump temporary cardiac assist system underwent clinical trials within the United States from 1988 to 1991. Use of the device proved life-saving in providing left ventricular assistance for failing hearts. Presentation of a case study demonstrating the effects of Hemopump support is provided along with a detailed nursing care plan. A brief discussion of peripartum cardiomyopathy is also included.
No takes yet. Share an insight, caveat, or question.
Abou-Awdi et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: